All
FDA appoints Deputy Commissioner for Human Foods to realize vision for proposed Human Foods Program
August 23rd 2023The U.S. Food and Drug Administration has appointed James “Jim” Jones as the first Deputy Commissioner for Human Foods. Jones will be in charge of setting and advancing priorities for a proposed unified Human Foods Program (HFP).
Industry stakeholders respond to request for information from Congress on hemp-derived CBD market
August 21st 2023The request seeks input on a range of factors, specifically: current market dynamics, pathways, scope, safety, quality, as well as form, packaging, accessibility and labeling. The deadline for submitting input was August 18, 2023.
Aker BioMarine announces successful NDIN for its Lysoveta ingredient
August 16th 2023Aker BioMarine has announced that its brain health ingredient, Lysoveta, has received an acknowledgement letter from the U.S. Food and Drug Administration (FDA) following its new dietary ingredient notification (NDIN).
CRN sends letter urging ODSP to allocate proper resources to enforcing NDI master file framework
August 11th 2023The Council for Responsible Nutrition has sent a letter to Cara Welch, PhD, director of the Office of Dietary Supplement Programs, urging the ODSP to allocate the necessary resources to effectively enforce the dietary supplement master file framework.
Stauber Performance Ingredients will distribute Probiotical’s SkinBac postbiotics in North America
August 11th 2023Probiotical SpA has announced that Stauber Performance Ingredients Inc. will be the North American distributor of SkinBac, the company’s family of multi-strain skin-targeting postbiotics.